After losing their son, a couple in Greece decided to undergo artificial insemination using an egg that had been frozen for many years.
AI-generated summary
In Greece there is a legal age limit for artificial insemination at 54 years. The birth rate in the country has fallen sharply in recent years.
Greek woman Cristina Rapti-Tzelepi and her husband experienced a tragedy in October - their then 21-year-old son died in a traffic accident. A few months later, the couple decided to use a fertilized egg frozen 22 years ago to have another child.
The two of them had to be quick: Rapti-Tzelepi was about to turn 54 and thus reach the end of a deadline to legally undergo artificial insemination in Greece.
“I only had a two-and-a-half month window,” Rapti-Tzelepi said. “It was stressful, but with inner strength and our doctor and his entire team by our side, we overcame every obstacle.”
On Wednesday last week, Rapti-Tzelepi, now 54, celebrated the birth of her second child - she gave birth to a girl in Athens. Their daughter weighed 3,490 grams. The parents' joy was visible on Friday as they sat in a hospital room decorated with pink balloons and flowers.
“We decided to give life a second chance, to have a fresh start, to bring new life into our home and to keep our family’s story going,” said Rapti-Tzelepi. “My wish for her is that she grows up healthy and happy, full of joy like our first child who filled our home with laughter.”
The frozen fertilized egg that gave birth to her daughter was 22 years old, making her unusually old. But last year in the US state of Ohio, a boy was born using a fertilized egg that was frozen more than 30 years ago.
Rapti-Tzelepi gynecologist Kostas Pantos called for a revision of Greek law on artificial insemination, citing the sharp decline in the country's birth rate. “The law is very strict: 54 plus one day is not allowed,” he said. "Maybe it's time for it to change. I think it's a right that shouldn't be taken away from parents."
The girl's 60-year-old father, Constantinos Raptis, said he was deeply grateful that the doctor had given his family hope again. “He took us by the hand and pulled us out of our deepest darkness,” Raptis said. “We have escaped that darkness and I believe we now have much to live for.”
The girl was named Georgia in honor of her late brother Giorgos. Giorgos was also born using artificial insemination. The children's parents did not rule out another attempt to have a child - they might go abroad to do so.
A large-scale fire department operation is underway at a high school in Dresden after numerous students complained of dry coughs. Around 440 people were evacuated and 42 complained of symptoms. The cause is unclear.

The Mainz-based biotech company Biontech and OncoC4 have almost doubled the survival time in lung cancer patients in a clinical phase 3 study with the antibody Gotistobart. The share temporarily rose by four percent.

The Mainz-based biotech company Biontech and OncoC4 have almost doubled the survival time for advanced lung cancer in a clinical study with the active ingredient Gotistobart. Subjects achieved a median survival of 18.5 months.
According to a study, artificial lighting at night is linked to negative changes in heart structure and function. Data from around 11,000 participants in the UK Biobank were evaluated.

Astra Zeneca's breast cancer drug Camizestrant failed in an advanced study to slow tumor recurrence or growth better than standard treatment.
According to authorities, over 7,000 cases and around 3,400 deaths have been reported in the Ebola outbreak in the Democratic Republic of Congo. The outbreak has spread to a seventh province, while a slight decline in cases is observed in Ituri province. There is currently no specific vaccine or therapy against the Bundibugyo type of virus.